Alterations in skin and stratified epithelia by constitutively activated PPARα. CommentaryDUBRAC, Sandrine; SCHMUTH, Matthias; QIAN YANG et al.Journal of investigative dermatology. 2006, Vol 126, Num 2, issn 0022-202X, 241-242,374-385 [14 p.]Article

A novel peroxisome proliferator-activated receptor α/γ dual agonist demonstrates favorable effects on lipid homeostasisGUO, Qiu; SAHOO, Soumya P; SHARMA, Neelam et al.Endocrinology (Philadelphia). 2004, Vol 145, Num 4, pp 1640-1648, issn 0013-7227, 9 p.Article

JAZF1 regulates visfatin expression in adipocytes via PPARα and PPARβ/δ signalingMING, Guang-Feng; XI LI; YIN, Ji-Ye et al.Metabolism, clinical and experimental. 2014, Vol 63, Num 8, pp 1012-1021, issn 0026-0495, 10 p.Article

β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathyANTONELLI, Alessandro; FERRARI, Silvia Martina; FRASCERRA, Silvia et al.Journal of endocrinology. 2012, Vol 213, Num 2, pp 183-191, issn 0022-0795, 9 p.Article

Systemic and Distal Repercussions of Liver-Specific Peroxisome Proliferator-Activated Receptor-α Control of the Acute-Phase ResponseMANSOURI, Roxane M; BAUGE, Eric; STAELS, Bart et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 6, pp 3215-3223, issn 0013-7227, 9 p.Article

Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor αNG, Valerie Y; YONG HUANG; MANMOHAN REDDY, L et al.Drug metabolism and disposition. 2007, Vol 35, Num 7, pp 1126-1134, issn 0090-9556, 9 p.Article

Metabolic and cellular plasticity in white adipose tissue. II role of peroxisome proliferator-activated receptor-αPIPENG LI; ZHENGXIAN ZHU; YUYAN LU et al.American journal of physiology. Endocrinology and metabolism. 2005, Vol 52, Num 4, pp E617-E626, issn 0193-1849Article

Peroxisome proliferators and peroxisome proliferator-activated receptor α: Biotic and xenobiotic sensingREDDY, Janardan K.The American journal of pathology. 2004, Vol 164, Num 6, pp 2305-2321, issn 0002-9440, 17 p.Article

Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor αMUKHERJEE, Ranjan; SHAOXIAN SUN; MURPHY, Kathleen et al.Journal of steroid biochemistry and molecular biology. 2002, Vol 81, Num 3, pp 217-225, issn 0960-0760, 9 p.Article

Therapeutic Potential of Peroxisome Proliferators-Activated Receptor-α/γ Dual Agonist With Alleviation of Endoplasmic Reticulum Stress for the Treatment of DiabetesKYU LEE HAN; JOO SUN CHOI; JAE YOUNG LEE et al.Diabetes (New York, NY). 2008, Vol 57, Num 3, pp 737-745, issn 0012-1797, 9 p.Article

Peroxisome proliferator-activated receptor α gene variation influences age of onset and progression of type 2 diabetesFLAVELL, David M; IRELAND, Helen; STEPHENS, Jeffrey W et al.Diabetes (New York, NY). 2005, Vol 54, Num 2, pp 582-586, issn 0012-1797, 5 p.Article

mTORC1 controls fasting-induced ketogenesis and its modulation by ageingSENGUPTA, Shomit; PETERSON, Timothy R; LAPLANTE, Mathieu et al.Nature (London). 2010, Vol 468, Num 7327, pp 1100-1104, issn 0028-0836, 5 p.Article

Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor α/γ agonist, after a single oral and intravenous dose in humansERICSSON, H; HAMREN, B; BERGSTRAND, S et al.Drug metabolism and disposition. 2004, Vol 32, Num 9, pp 923-929, issn 0090-9556, 7 p.Article

Peroxisome proliferator-activated receptor-α and glucocorticoids interactively regulate insulin secretion during pregnancyHOLNESS, Mark J; GREENWOOD, Gemma K; SMITH, Nicholas D et al.Diabetes (New York, NY). 2006, Vol 55, Num 12, pp 3501-3508, issn 0012-1797, 8 p.Article

PPARα activation potentiates AhR-induced CYP1A1 expressionFALLONE, Frédérique; VILLARD, Pierre-Henri; DECOME, Laetitia et al.Toxicology (Amsterdam). 2005, Vol 216, Num 2-3, pp 122-128, issn 0300-483X, 7 p.Article

Cell cross-talk mediates PPARα null hepatocyte proliferation after peroxisome proliferator exposureWEGLARZ, Teresa C; SANDGREN, Eric P.Carcinogenesis (New York. Print). 2004, Vol 25, Num 1, pp 107-112, issn 0143-3334, 6 p.Article

Molecular analysis of peroxisome proliferation in the hamsterCHOUDHURY, Agharul I; SIMS, Helen M; BELLS, David R et al.Toxicology and applied pharmacology. 2004, Vol 197, Num 1, pp 9-18, issn 0041-008X, 10 p.Article

PPARu ligands: Benefits and mechanistic cancer risk assessmentSCHRAMM, Carolin; ROBERTS, Ruth A.Recent research developments in cancer : Vol. 4 (2002) - Part II. Recent research developments in cancer. 2002, pp 569-589, isbn 81-7895-051-0, 21 p.Book Chapter

Increased expression of oxidative enzymes in adipose tissue following PPARα-activationMATOS FERREIRA, Adaliene Versiani; MENEZES-GARCIA, Zélia; GUILHEN MARIO, Erica et al.Metabolism, clinical and experimental. 2014, Vol 63, Num 4, pp 456-460, issn 0026-0495, 5 p.Article

The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARα-independent mechanismLARSEN, Søren Thor; NIELSEN, Gunnar Damgard.Toxicology letters. 2007, Vol 170, Num 3, pp 223-228, issn 0378-4274, 6 p.Article

Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor α to Wy-14,643-induced liver tumorigenesisMORIMURA, Keiichirou; CHEUNG, Connie; WARD, Jerrold M et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 5, pp 1074-1080, issn 0143-3334, 7 p.Article

Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-α agonist treatment is accompanied by paradoxical increase of circulating resistin levelsHALUZIK, M. M; LACINOVA, Z; DOLINKOVA, M et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 9, pp 4517-4524, issn 0013-7227, 8 p.Article

Plasma free fatty acids and peroxisome proliferator-activated receptor α in the control of myocardial uncoupling protein levelsMURRAY, Andrew J; PANAGIA, Marcello; HAUTON, David et al.Diabetes (New York, NY). 2005, Vol 54, Num 12, pp 3496-3502, issn 0012-1797, 7 p.Article

Examining the safety of PPAR agonists ― current trends and future prospectsBORTOLINI, Michele; WRIGHT, Matthew B; BOPST, Martin et al.Expert opinion on drug safety. 2013, Vol 12, Num 1, pp 65-79, issn 1474-0338, 15 p.Article

Peroxisome Proliferator-Activated Receptors-α and -γ, and cAMP-Mediated Pathways, Control Retinol-Binding Protein-4 Gene Expression in Brown Adipose TissueROSELL, Meritxell; HONDARES, Elayne; VILLARROYA, Francesc et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 3, pp 1162-1173, issn 0013-7227, 12 p.Article